Kura Oncology Inc (KURA) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.55x

Kura Oncology Inc (KURA) has a Cash Flow Reinvestment Rate of 0.55x as of December 2025, reinvesting $64.60 Million (capex $2.32 Million plus investments $-62.27 Million) from operating cash flow of $117.27 Million. Explore how efficiently does Kura Oncology Inc generate cash to assess how effectively this company generates cash.

Reinvestment Rate

0.55x

(Capex + Investments) / Operating CF

Total Reinvested

$64.60 Million

Capex + Investments

Operating Cash Flow

$117.27 Million

USD

Capital Expenditures

$2.32 Million

USD

Kura Oncology Inc Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for Kura Oncology Inc across 1 annual periods. Explore KURA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Kura Oncology Inc (2024–2024)

Year-by-year capital reinvestment analysis for Kura Oncology Inc. For live market cap and broader valuation context, see KURA market cap.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2024	0.76x	$102.06 Million	$134.32 Million	$472.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow